Evidence map›Paper›PMID 25917103›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.

Venkatesh L Hegde, Udai P Singh, Prakash S Nagarkatti, Mitzi Nagarkatti

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02786420 (Imaging Innovations for Placental Assessment in Response to Environmental Pollution), which is not on this map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02786420 completednot on this map

Imaging Innovations for Placental Assessment in Response to Environmental Pollution

TypeobservationalSponsorUniversity of California, Los AngelesRan2015 to 2020Enrolled199ConditionsPlacental Disease
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Chemical Profiling of Polyphenolic Fraction ofPlants (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Targeting the myeloid microenvironment in neuroblastoma.Journal of experimental & clinical cancer research : CR · 2023
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Venkatesh L HegdeDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC 29209; and.
Udai P SinghDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC 29209; and.
Prakash S NagarkattiDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC 29209; and.
Mitzi NagarkattiDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC 29209; and Wm. Jennings Bryan Dorn Veterans Affairs Medical Center, Columbia, SC 29208 mnagark@uscmed.sc.edu.
University of South Carolina · US

Funding

Targeting early ceramide elevation in pre-symptomatic eczemaP20GM103641 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, PRAKASH S · 2012 to 2023
$20.7M
Use of Resveratrol to treat experimental multiple sclerosisP01AT003961 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HOFSETH, LORNE J · 2007 to 2018
$14.2M
Role of natural indoles in experimental autoimmune encephalomyelitisR01AT006888 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI · 2011 to 2015
$2.0M
Immunopathological basis of PTSDR01MH094755 · NIMH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, PRAKASH S · 2011 to 2015
$1.7M
Estrogen-T cell InteractionsR01ES019313 · NIEHS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI, NAGARKATTI, PRAKASH S · 2010 to 2014
$1.5M
Cannabidiol and immunosuppression: Mechanism of induction and role of MDSCsK01DA034892 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HEGDE, VENKATESH L · 2014 to 2016
$492k
Role of CD44 in experimental Multiple SclerosisI01BX001357 · VA · VETERANS HEALTH ADMINISTRATION · PI NAGARKATTI, MITZI · 2012 to 2015
–
BLRD VA I01 BX001357NCCIH NIH HHS P01 AT003961NCCIH NIH HHS P01AT003961NCCIH NIH HHS R01 AT006888NCCIH NIH HHS R01AT006888NCRR NIH HHS P20RR032684NIDA NIH HHS K01 DA034892NIDA NIH HHS K01DA034892NIEHS NIH HHS R01 ES019313NIEHS NIH HHS R01ES019313NIGMS NIH HHS P20 GM103641NIMH NIH HHS R01 MH094755NIMH NIH HHS R01MH094755
6 · The paper itself

Abstract

Cannabidiol (CBD) is a natural nonpsychotropic cannabinoid from marijuana (Cannabis sativa) with anti-epileptic and anti-inflammatory properties. Effect of CBD on naive immune system is not precisely understood. In this study, we observed that administering CBD into naive mice triggers robust induction of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSC) in the peritoneum, which expressed functional arginase 1, and potently suppressed T cell proliferation ex vivo. Furthermore, CBD-MDSC suppressed LPS-induced acute inflammatory response upon adoptive transfer in vivo. CBD-induced suppressor cells were comprised of CD11b(+)Ly6-G(+)Ly6-C(+) granulocytic and CD11b(+)Ly6-G(-)Ly6-C(+) monocytic subtypes, with monocytic MDSC exhibiting higher T cell-suppressive function. Induction of MDSC by CBD was markedly attenuated in Kit-mutant (Kit(W/W-v)) mast cell-deficient mice. MDSC response was reconstituted upon transfer of wild-type bone marrow-derived mast cells in Kit(W/W-v) mice, suggesting the key role of cKit (CD117) as well as mast cells. Moreover, mast cell activator compound 48/80 induced significant levels of MDSC in vivo. CBD administration in mice induced G-CSF, CXCL1, and M-CSF, but not GM-CSF. G-CSF was found to play a key role in MDSC mobilization inasmuch as neutralizing G-CSF caused a significant decrease in MDSC. Lastly, CBD enhanced the transcriptional activity of peroxisome proliferator-activated receptor γ in luciferase reporter assay, and PPAR-γ selective antagonist completely inhibited MDSC induction in vivo, suggesting its critical role. Together, the results suggest that CBD may induce activation of PPAR-γ in mast cells leading to secretion of G-CSF and consequent MDSC mobilization. CBD being a major component of Cannabis, our study indicates that marijuana may modulate or dysregulate the immune system by mobilizing MDSC.

Indexed as

AnimalsAnti-Inflammatory AgentsArginaseCannabidiolCannabisCD11b AntigenCell ProliferationChemokine CXCL1FemaleGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorMacrophage Colony-Stimulating FactorMast CellsMiceMice, Inbred C57BLMice, KnockoutAnti-Inflammatory AgentsArg1 protein, mouseArginaseCannabidiolCD11b AntigenChemokine CXCL1Cxcl1 protein, mouseGr-1 protein, mouseGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorMacrophage Colony-Stimulating Factorp-Methoxy-N-methylphenethylaminePPAR gammaReceptors, Chemokine

Identifiers

PMID25917103
PMCPMC4433789
OpenAlexW1945418123

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.